InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Pharming Group N.V.

PHAR Clue Score60
Netherlands Fiscal year ends December CIK 0001828316
$9.61 -1.84% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $9.61 +6.54% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 23 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Fiscal year 2019Revenue189.4Operating income68.2Net income40.6EPS, diluted0.06Fiscal year 2020Revenue212.2 +12.0%Operating income76.3Net income37.7 −6.9%EPS, diluted0.06 −8.3%Fiscal year 2021Revenue198.9 −6.3%Operating income13.6Net income16.0 −57.6%EPS, diluted0.02 −58.2%Fiscal year 2022Revenue205.6 +3.4%Operating income18.2Net income13.7 −14.5%EPS, diluted0.02 −17.4%Fiscal year 2023Revenue245.3 +19.3%Operating income−5.4Net income−10.5 −177.1%EPS, diluted−0.02 −184.2%Fiscal year 2024Revenue297.2 +21.1%Operating income−8.6Net income−11.8EPS, diluted−0.02Fiscal year 2025Revenue376.1 +26.6%Operating income25.8Net income2.9EPS, diluted0.00
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 189.4 212.2 198.9 205.6 245.3 297.2 376.1
Growth +12.0% −6.3% +3.4% +19.3% +21.1% +26.6%
Operating income n/a 68.2 76.3 13.6 18.2 −5.4 −8.6 25.8
Net income n/a 40.6 37.7 16.0 13.7 −10.5 −11.8 2.9
Growth −6.9% −57.6% −14.5% −177.1%
EPS, diluted n/a 0.06 0.06 0.02 0.02 −0.02 −0.02 0.00
Growth −8.3% −58.2% −17.4% −184.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Fiscal year 2019Gross margin87.4%Operating margin36.0%Net margin21.4%Free cash flow margin37.8%Fiscal year 2020Gross margin88.9%Operating margin35.9%Net margin17.8%Free cash flow margin37.2%Fiscal year 2021Gross margin89.4%Operating margin6.8%Net margin8.0%Free cash flow margin13.6%Fiscal year 2022Gross margin91.5%Operating margin8.9%Net margin6.7%Free cash flow margin10.3%Fiscal year 2023Gross margin89.7%Operating margin−2.2%Net margin−4.3%Free cash flow margin−7.6%Fiscal year 2024Gross margin88.1%Operating margin−2.9%Net margin−4.0%Free cash flow margin−0.9%Fiscal year 2025Gross margin87.9%Operating margin6.9%Net margin0.8%Free cash flow margin14.3%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 87.4% 88.9% 89.4% 91.5% 89.7% 88.1% 87.9%
Operating margin n/a 36.0% 35.9% 6.8% 8.9% −2.2% −2.9% 6.9%
Net margin n/a 21.4% 17.8% 8.0% 6.7% −4.3% −4.0% 0.8%
Free cash flow margin n/a 37.8% 37.2% 13.6% 10.3% −7.6% −0.9% 14.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Fiscal year 2019Operating cash flow74.1Capital expenditure−2.6Free cash flow71.5Fiscal year 2020Operating cash flow83.6Capital expenditure−4.7Free cash flow79.0 +10.4%Fiscal year 2021Operating cash flow37.8Capital expenditure−10.7Free cash flow27.1 −65.7%Fiscal year 2022Operating cash flow22.5Capital expenditure−1.4Free cash flow21.1 −22.2%Fiscal year 2023Operating cash flow−17.3Capital expenditure−1.4Free cash flow−18.7 −188.9%Fiscal year 2024Operating cash flow−1.8Capital expenditure−0.8Free cash flow−2.6Fiscal year 2025Operating cash flow54.7Capital expenditure−0.7Free cash flow54.0
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a 74.1 83.6 37.8 22.5 −17.3 −1.8 54.7
Capital expenditure n/a −2.6 −4.7 −10.7 −1.4 −1.4 −0.8 −0.7
Free cash flow n/a 71.5 79.0 27.1 21.1 −18.7 −2.6 54.0
Growth +10.4% −65.7% −22.2% −188.9%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2018Cash91.9Shareholders’ equity64.1Fiscal year 2019Cash74.3Shareholders’ equity117.4Fiscal year 2020Cash205.2Shareholders’ equity183.4Fiscal year 2021Cash191.9Shareholders’ equity192.9Fiscal year 2022Cash207.3Shareholders’ equity204.6Fiscal year 2023Cash61.7Shareholders’ equity218.8Fiscal year 2024Cash54.9Shareholders’ equity221.1Fiscal year 2025Cash145.3Shareholders’ equity277.1
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 91.9 74.3 205.2 191.9 207.3 61.7 54.9 145.3
Shareholders’ equity 64.1 117.4 183.4 192.9 204.6 218.8 221.1 277.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 189.4 212.2 198.9 205.6 245.3 297.2 376.1
Growth +12.0% −6.3% +3.4% +19.3% +21.1% +26.6%
n/a 23.9 23.5 21.1 17.6 25.2 35.4 45.5
n/a 165.5 188.6 177.7 188.1 220.1 261.8 330.6
Growth +14.0% −5.8% +5.8% +17.0% +18.9% +26.3%
n/a 31.8 38.5 70.4 52.5 68.9 83.1 100.4
n/a 21.2 24.1 37.0 46.0 55.9 70.7 80.0
n/a 68.2 76.3 13.6 18.2 −5.4 −8.6 25.8
Growth +11.7% −82.2% +34.5% −129.5%
n/a 52.3 44.1 23.1 15.0 −12.0 −8.5 12.8
n/a 11.7 6.3 7.1 1.3 −1.5 3.3 10.3
n/a 40.6 37.7 16.0 13.7 −10.5 −11.8 2.9
Growth −6.9% −57.6% −14.5% −177.1%
Per share
n/a 0.07 0.06 0.03 0.02 −0.02 −0.02 0.00
n/a 0.06 0.06 0.02 0.02 −0.02 −0.02 0.00
Growth −8.3% −58.2% −17.4% −184.2%
606.6 626.3 636.3 642.0 648.7 657.0 671.3 688.8
653.5 673.5 682.7 701.2 707.1 725.5 785.4 746.9
Growth +3.1% +1.4% +2.7% +0.9% +2.6% +8.3% −4.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 12.1% a year over five years, and earnings per share fell 40.8% a year.
  • The diluted share count rose 9.4% in five years, which is dilution.
  • Operating margin is down 29.1 points on five years ago, at 6.9%.
  • A net loss in 2 of 7 years on file.